Milvexian
N/A
Report date: 2024/03/28 15:56:02
NME
Base Information
Drug NameMilvexian
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[12]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[50]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A
Develop Information
Active CompaniesBristol Myers Squibb SrlcompanyJohnson & Johnson (China) Investment LtdJanssen, Lp +[8]
Inactive CompaniesN/A
Active Indications +[9]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A